• Molecules and Cells
• /
• 제27권6호
• /
• pp.621-627
• /
• 2009

Spinocerebellar ataxia type 1 (SCA1) is an autosomal-dominant neurodegenerative disorder characterized by ataxia and progressive motor deterioration. SCA1 is associated with an elongated polyglutamine tract in ataxin-1, the SCA1 gene product. As summarized in this review, recent studies have clarified the molecular mechanisms of SCA1 pathogenesis and provided direction for future therapeutic approaches. The nucleus is the subcellular site where misfolded mutant ataxin-1 acts to cause SCA1 disease in the cerebellum. The role of these nuclear aggregates is the subject of intensive study. Additional proteins have been identified, whose conformational alterations occurring through interactions with the polyglutamine tract itself or non-polyglutamine regions in ataxin-1 are the cause of SCA-1 cytotoxicity. Therapeutic hope comes from the observations concerning the reduction of nuclear aggregation and alleviation of the pathogenic phenotype by the application of potent inhibitors and RNA interference.

• 생명과학회지
• /
• 제21권5호
• /
• pp.671-677
• /
• 2011

대두의 세포막에 존재하는 SCA1은 칼모듈린에 의해서 조절된다는 내용을 이전에 보고하였다. 본 연구에서는 대두의 $Ca^{2+}$-ATPase인 SCA2에 관한 특성을 연구하였다. SCA2는 SCA1과 아미노산 서열 비교에서 78%로 높은 유사성을 나타내며, 10개의 transmembrane 도메인이 존재하는 것을 확인하였다. CaM overaly assay로부터, SCA2는 칼슘에 의존적인 방법으로 칼모듈린과 결합한다는 것을 보여주었으며, Southern blot 분석 결과, 대두의 genome에는 두 종류의 $Ca^{2+}$-ATPase가 존재하는 것으로 보인다. SCA2의 $Ca^{2+}$-ATPase 효소활성을 확인하고자 yeast mutant를 이용하여 complementation assay를 수행해 보면, SCA2가 $Ca^{2+}$-ATPase의 효소활성을 가지는 것을 보여 주었다. 이러한 결과들은 SCA2가 식물에 존재하는 type IIB $Ca^{2+}$-ATPase들과 구조적으로 높은 유사성을 가진다는 것을 시사한다.

• Journal of Genetic Medicine
• /
• 제4권1호
• /
• pp.22-37
• /
• 2007

The autosomal dominant spinocerebellar ataxias (SCAs) are a group of neurodegenerative diseases, clinically and genetically heterogeneous, characterized by degeneration of spinocerebellar pathways with variable involvement of other neural systems. At present, 27 distinct genetic forms of SCAs are known: SCA1-8, SCA10-21, SCA23, SCA25-28, DRPLA (dentatorubral-pallidoluysian atrophy), and 16q-liked ADCA (autosomal dominant cerebellar ataxia). Epidemiological data about the prevalence of SCAs are restricted to a few studies of isolated geographical regions, and most do not reflect the real occurrence of the disease. In general a prevalence of about 0.3-2 cases per 100,000 people is assumed. As SCA are highly heterogeneous, the prevalence of specific subtypes varies between different ethnic and continental populations. Most recent data suggest that SCA3 is the commonest subtype worldwide; SCA1, SCA2, SCA6, SCA7, and SCA8 have a prevalence of over 2%, and the remaining SCAs are thought to be rare (prevalence <1%). In this review, we highlight and discuss the SCA7. The hallmark of SCA7 is the association of hereditary ataxia and visual loss caused by pigmentary macular degeneration. Visual failure is progressive, bilateral and symmetrical, and leads irreversibly to blindness. This association represents a distinct disease entity classified as autosomal dominant cerebellar ataxia (ADCA) type II by Harding. The disease affectsprimarily the cerebellum and the retina by the moderate to severe neuronal loss and gliosis, but also many other central nervous system structures as the disease progresses. SCA7 is caused by expansion of an unstable trinucleotide CAG repeat in the ATXN7 gene encoding a polyglutamine (polyQ) tract in the corresponding protein, ataxin-7. Normal ATXN7 alleles contain 4-35 CAG repeats, whereas pathological alleles contain from 36->450 CAG repeats. Immunoblott analysis demonstrated that ataxin-7 is widely expressed but that expression levels vary among tissues. Instability of expanded repeats is more pronounced in SCA7 than in other SCA subtypes and can cause substantial lowering of age at onset in successive generations termed ‘anticipation’ so that children may become diseased even before their parents develop symptoms. The strong anticipation in SCA7 and the rarity of contractions should have led to its extinction within a few generations. There is no specific drug therapy for this neurodegenerative disorder. Currently, therapy remains purely symptomatic. Cellular models and SCA7 transgenic mice have been generated which constitute valuable resources for studying the disease mechanism. Understanding the pathogenetic mechanisms of neurodegeneration in SCAs should lead to the identification of potential therapeutic targets and ultimately facilitate drug discovery. Here we summarize the clinical, pathological, and genetic aspects of SCA7, and review the current understanding of the pathogenesis of this disorder. Further, we also review the potential therapeutic strategies that are currently being explored in polyglutamine diseases.

• 생명과학회지
• /
• 제16권1호
• /
• pp.76-81
• /
• 2006

방선균에서 DNA 전사 억제인자로써 작용하여 이차대사산물의 생산뿐만 아니라 형태분화를 조절하는 $\gamma-butyrolactone$ autoregulator receptor를 암호화하는 유전자(scaR)를 clavulanic arid 생산 균주, Streptomyces clavuligerus로부터 클로닝하고 in vitro에서 ScaR의 특징을 연구하여 보고한 바 있다. 따라서 본 연구에서는 ScaR의 in vivo 기능을 분석하기위해 상동재조합방법을 이용하여 scaR이 제거된 변이주를 제작하고 야생균주와 표현형을 비교해 보았다. 그 결과, Streptomyces clavuligerus의 형태분화에서는 큰 차이를 나타내지 않았지만 clavulanic acid의 생산에 있어서는 scaR 파괴 변이주가 야생균주에 비해 생산이 증가된 경향을 보였다. 그러므로 ScaR이 S. clavuligerus의 형태분화에는 영향을 미치지 않지만 clavulanic acid 생합성에는 negative regulator로 작용한다는 것을 본 연구를 통해 명확하게 확인할 수 있었다.

• Molecules and Cells
• /
• 제19권1호
• /
• pp.23-30
• /
• 2005

Spinocerebellar ataxia type 1 (SCA1) is an autosomal-dominant neurodegenerative disorder caused by expansion of the polyglutamine tract in the SCA1 gene product, ataxin-1. Using d2EGFP, a short-lived enhanced green fluorescent protein, we investigated whether polyglutamine-expanded ataxin-1 affects the function of the proteasome, a cellular multicatalytic protease that degrades most misfolded proteins and regulatory proteins. In Western blot analysis and immunofluorescence experiments, d2EGFP was less degraded in HEK 293T cells transfected with ataxin-1(82Q) than in cells transfected with lacZ or empty vector controls. To test whether the stability of the d2EGFP protein was due to aggregation of ataxin-1, we constructed a plasmid carrying $ataxin-1-{\Delta}114$, lacking the self-association region (SAR), and examined degradation of the d2EGFP. Both the level of $ataxin-1-{\Delta}114$ aggregates and the amount of d2EGFP were drastically reduced in cells containing $ataxin-1-{\Delta}114$. Furthermore, d2EGFP localization experiments showed that polyglutamine-expanded ataxin-1 inhibited the general function of the proteasome activity. Taken together, these results demonstrate that polyglutamine-expanded ataxin-1 decreases the activity of the proteasome, implying that a disturbance in the ubiquitin-proteasome pathway is directly involved in the development of spinocerebellar ataxia type1.

• 대한한방내과학회지
• /
• 제42권5호
• /
• pp.784-792
• /
• 2021

Objectives: The purpose of this study was to investigate a case of a patient with spinocerebellar ataxia (SCA) type 2 whose condition improved following treatment with Korean medicine. Methods: A 25-year-old man, diagnosed with SCA type 2, was treated with herbal medicine (Yukmijiwhang-tang-gami), acupuncture, and physical treatment. The therapeutic effect was evaluated using the Berg Balance Scale (BBS) and gait status. Results: Following treatment, the BBS score increased, and gait ataxia improved. Conclusions: This case study suggests that Korean medicine could be effective for relieving symptoms of SCA type 2.

• 동의생리병리학회지
• /
• 제27권6호
• /
• pp.842-846
• /
• 2013

The purpose of this study was to report one clinical case of spinocerebellar ataxia(SCA) type 1 improved by herbal medicine and oriental medical treatment. As a treatment, Yukmijihwang-tang(Liuweidihuangtang)-gamibang, acupuncture, and moxa were tried upon the patient for 21 days in order to relieve the symptoms. In terms of observing the changes of symptoms, the progress of patient's condition was evaluated periodically by using the Korean-mini mental state examination(K-MMSE), Modified Barthel Index(MBI), Functional Independence Measure(FIM). In accordance with the observation under K-MMSE, MBI, FIM, the patient's symptoms had gradually improved throughout the treatment. Therefore, this report suggests that Yukmijihwang-tang(Liuweidihuangtang)-gamibang, acupuncture and moxa were probably effective in the treatment of SCA type 1.

• Annals of Clinical Neurophysiology
• /
• 제9권2호
• /
• pp.102-104
• /
• 2007

Spinocerebellar ataxia type 2 (SCA2) is characterized by progressive cerebellar ataxia and slow saccades. A 40-year-old woman presented with progressive gait disturbance and ataxia over 15 years. Neurologic examination revealed scanning speech, ataxia, and hyporeflexia. Brain CT showed diffuse atrophy of the cerebellum. Electronystagmography demonstrated slowed saccades with normal accuracy and delayed latency. The diagnosis of SCA2 was confirmed by the genetic test. Documentation of slow saccades may help differentiation among SCA subgroups.

• 한국작물학회지
• /
• 제51권7호
• /
• pp.652-657
• /
• 2006

참깨는 무한화의 특성을 지니고 있어 수확시 필연적으로 미등숙 종실의 발생과 탈립으로 인한 수량 손실이 발생하는 등 재배상 여러 가지 문제점을 야기하는데, 현재 개발되고 있는 내탈립성 참깨들은 이러한 문제점을 해결해 줄 수 있을 것으로 기대되고 있다. 본 연구는 새로 개발된 내탈립성 참깨와 기존품종들 간의 이면교잡을 실시하여 탈립성을 포함한 주요양적형질에 대한 잡종강세 및 조합능력을 분석하였으며, 그 결과를 요약하면 다음과 같다. 1. 탈립율은 모든 조합에서 탈립율이 증가하는 방향으로 잡종강세가 작용하였으며 PA형(수원195호)/ID형(SIG960320-5-1-1) 조합에서 가장 컸는데, 이는 탈립 저항성과 관련된 형질이 모두 열성으로 $F_{1}$ 세대에서는 그 특성이 발현되지 않았기 때문이었다. 2. 잡종강세 발현은 주당삭수, 주당수량 및 분지수 등에서 컸으며, 경장과 착삭부위장에서는 적게 나타났다. 3. 일반조합능력(GCA)은 6개 형질 모두에서 유의성이 인정되었으며, 특정조합능력(SCA)에서는 탈립율, 주당삭수 및 주당수량에서 유의성을 보였다. 4. 모든 형질에서 GCA분산이 SCA 분산보다 커서 상가적 유전자 작용의 효과가 더 큰 것으로 추정되었다. 5. 교배친의 GCA 검정에서 수원195호는 탈립율과 경장의 감소효과가 크고 주당삭수와 주당수량을 증대시키는 효과를, SIG96320-5-1-1은 주당수량 감소와 경장을 증가시키는 효과를 보였다. 교배조합별 SCA는 양백깨/수원195호 조합은 주당삭수 증대면에서, 안산깨/SIG96320-5-1-1 조합은 주당수량 증대면에서, 안산깨/수원177호 조합은 탈립율 감소면에서 가장 큰 효과를 나타냈다.

• 대한한방내과학회지
• /
• 제37권2호
• /
• pp.322-329
• /
• 2016

Objective: This study reports on one clinical case of type 3 spinocerebellar ataxia (SCA) to examine the effectiveness of herbal medicine and traditional Korean treatments.Methods: A patient with type 3 spinocerebellar ataxia was treated using traditional Korean medicine options such as acupuncture and Hyangsayukgunja-tang. The effects on type 3 spinocerebellar ataxia were measured using the numeric rating scale (NRS) and ambulatory status.Results: Improvements in NRS and ambulatory status were observed after treatment.Conclusion: According to this study, traditional Korean medicine may be effective in the treatment of type 3 spinocerebellar ataxia.